MODAG

Private

WendelsheimHealthcare & Life Scienceshttps://www.modag.net/

Last Round

Grant

Dec 12, 2023

Total Funding Raised

$17.3M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

MODAG is a biotechnology company that focuses on the research and development of therapeutics and diagnostics for neurodegenerative diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical Devices, Medical Imaging

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

synucleinopathiesdisease-modifying therapyalpha-synuclein targetsmall molecule therapyMultiple System AtrophyMSAParkinson's diseasePDprotein aggregation inhibitoroligomer modulatorneurodegenerative diseaseclinical-stage biotechPET tracerspharma licensingmolecular imagingblood-brain barrier penetrantAlzheimer's disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MODAG Comps

Public and private peers based on sector, stage, and business model.

MODAG comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MODAG Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Dec 12, 2023
Grant	Aug 5, 2020
Series A	Jun 27, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Andreas Kranzusch

CFO

Executive Team

MODAG Investors

Notable investors and investment history

MODAG investors
Investor	Rounds
The Michael J. Fox Foundation for Parkinson's Research	Grant
Max Planck Society for the Advancement of Science	Series A
Massa Investment AG	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 18, 2026
Monthly visitors increased 31% MoM, reaching 1.1K.
Jan 1, 2026
Monthly visitors grew 291% MoM, from 310 to 1.2K.

View all signals

MODAG Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

MODAG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MODAG's valuation, stock price, and market status.

Firmographic Details

HeadquartersWendelsheim

Employee Range12

Year Founded2013

Last FundingDec 12, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.